“ibrutinib” Archives

in
Entry Author Date Location
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
ASH 2018: Three Up, Two Down as Big Blood Disease Meeting Rolls On 12/03/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
MEI Pharma Inks Cancer Drug Deal with Japan’s Kyowa Hakko Kirin 11/05/18 San Diego
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund 06/09/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More 03/19/15 Seattle
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
MD Anderson Showcases “Moon Shots” Progress in Fight Against Cancer 11/03/14 Texas
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Pharmacyclics, J&J Get FDA Nod for Chronic Lymphocytic Leukemia Drug 02/12/14 San Francisco
U.S. Biomedical Research at a Precipice 01/09/14 San Diego
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Pharmacyclics, J&J Win FDA Approval for Big Blood Cancer Drug 11/13/13 San Francisco
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing 08/16/13 Boston
East Coast Life Sciences Roundup: Alkermes, Ensemble, Sinai, & More 07/19/13 Boston
Page 1 of 1